Background and objectives: Higher phosphate is associated with mortality in dialysis
patients but few prospective studies assess this in nondialysis patients managed in an …

Elevated serum phosphate levels have been linked with vascular calcification and mortality
among dialysis patients. The relationship between phosphate and mortality has not been …

Background: Severe hyperphosphatemia (serum phosphate level> 6.5 mg/dL [> 2.10
mmol/L]) has been associated directly with increased overall and cardiovascular mortality in …

Background. Hyperphosphataemia is associated with increased mortality in patients with
chronic kidney disease (CKD) stage IV or on dialysis. Furthermore, in animal studies …

Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD).
Hyperphosphatemia is invariably present among patients with end-stage renal disease …

Hyperphosphatemia in end-stage renal disease patients: Pathophysiological
consequences. A study of 6407 end-stage renal disease (ESRD) patients has shown that …

Background. High serum phosphate has been identified as an important contributor to the
vascular calcification seen in patients with chronic kidney disease (Block et al., Am J Kidney …

Elevated serum phosphorus is a predictable accompaniment of end-stage renal disease
(ESRD) in the absence of dietary phosphate restriction or supplemental phosphate binders …

Results Older age and male sex were associated with lower phosphate levels. Instead,
higher phosphate levels were noted in patients with diabetes. Patients with phosphate …

BACKGROUND: Poor nutritional status and both hyper-and hypophosphatemia are
associated with increased mortality in maintenance hemodialysis (HD) patients. We …